ELX/TEZ/IVA

elexacaftor/tezacaftor/ivacaftor · Vertex Pharmaceuticals Incorporated

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for ELX/TEZ/IVA, covering 2023-06-28 to 2026-06-05. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA in Cystic Fibrosis Participants 12 Months of Age and Older [Phase 3]

See pricing